Herbas VPB

Print
EN | LT
LT - Stabilizuotos kompozicijos, kurių sudėtyje yra interleukino-6 (IL6R) receptorius blokuojantys antikūnai
EN - STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/00 (2006.01)
A61K 9/08 (2006.01)
A61K 31/485 (2006.01)
A61K 39/395 (2006.01)
A61K 47/18 (2017.01)
A61K 47/26 (2006.01)
A61P 19/00 (2006.01)
A61P 19/02 (2006.01)
A61P 25/00 (2006.01)
A61P 29/00 (2006.01)
A61P 37/02 (2006.01)
A61P 37/06 (2006.01)
C07K 16/24 (2006.01)
European patent
(11) Number of the document 3756652
(13) Kind of document T
(96) European patent application number 20184418.0
Date of filing the European patent application 2011-01-07
(97) Date of publication of the European application 2020-12-30
(45) Date of publication and mention of the grant of the patent 2022-06-22
(46) Date of publication of the claims translation 2022-09-12
Priority applications
(30) Number Date Country code
29322710 P 2010-01-08 US
Inventors
(72)
DIX, Daniel, B , US
GRAHAM, Kenneth, S. , US
KAMEN, Douglas, E. , US
WALSH, Scott, M. , US
Grantee
(73) Regeneron Pharmaceuticals, Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Stabilizuotos kompozicijos, kurių sudėtyje yra interleukino-6 (IL6R) receptorius blokuojantys antikūnai
  STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES
Last renewal fee
Payment date Validity (years) Amount
2024-12-18 15 289.00 EUR
Next renewal fee
2026-01-07